Indonesia has granted a Maryland-based biotech company its first emergency use authorization for its COVID-19 vaccine.
The vaccine developed by Novavax will be manufactured by the Serum Institute of India (SII) and marketed under the name COVOVAX.
The National Agency of Drug and Food Control of the Republic of Indonesia ...
from The Washington Times stories: Health https://ift.tt/3GKTMOi